Local Institution

Tours 37044

0 studies enrolling now · 9 studies all time

What they study most

Breast Cancer, Cancer, Congestive Heart Failure, Diabetic Kidney Disease, Lymphoma, Metastatic Breast Cancer, Multiple Myeloma, Non-small Cell Lung Cancer, Non-small Cell Lung Cancer (NSCLC), Renal Transplantation

Studies at this site

• Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
• A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL) — Completed
• Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer — Completed
• Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease — Stopped early
• Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant — Completed
• A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer — Completed
• Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer — Stopped early
• Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve) — Completed
• Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer) — Stopped early